Rep. Diana Harshbarger has introduced her first bill, legislation that she says could lead to lower prescription drug costs. To read the article, visit here.
Rep. Diana Harshbarger voted against two Democratic efforts to expand background check requirements for firearms sales. Click here to read the full article.
WASHINGTON (WJHL) — Neopharma’s pharmaceutical manufacturing facility in Bristol will keep its critical infrastructure designation even after the COVID-19 pandemic is over.
That’s according to Rep. Diana Harshbarger, who announced Thursday evening that the Cybersecurity and Infrastructure Security Agency (CISA) reaffirmed the facility’s status and said it will remain in place post-pandemic.
To read the full article, please visit here.
